NKTR compared with OKUR: revenue, margins and what each company keeps, and the suppliers and customers both name

NKTRNektar Therapeutics

Mkt capRevenueRevenue

OKUROnKure Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

NKTRNektar Therapeutics

OKUROnKure Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

NKTRNektar Therapeutics

37.09▼−4.57%

Mkt cap$1.3BRevenue$10MQ2 FY26Revenue$55MFY25

OKUROnKure Therapeutics, Inc.

2.60▼−0.76%

Regular sessionNov 2 '26

Mkt cap$106.1MRevenue—Revenue—

Compare

Regular sessionNov 2 '26

NKTRNektar Therapeutics

OKUROnKure Therapeutics, Inc.

37.09▼−4.57%

Price

2.60▼−0.76%

$1.3B

Mkt cap

$106.1M

Q2 FY26$10M

Revenue

—

FY25$55M

Revenue

—

NKTR37.09▼−4.57%vsOKUR2.60▼−0.76%Regular sessionNov 2 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NKTR: latest quarter is a loss; flow not drawable. OKUR: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NKTR 12

—UCBunlistedcustomer

—Baxalta (a subsidiary of Takeda Pharmaceutical Company Limited)unlistedcustomer

AZNAstraZenecacustomer

PFEPfizercustomer

8 more · NKTR chain ›

Shared 0

No shared counterparties.

Only OKUR 2

—PharmaBlock Sciences (Nanjing)unlistedsupplier

—STA Pharmaceutical Hong Kongunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

NKTR, solidOKUR, dashed